Professor at Shanghai University of Medicine and Health Sciences and Tel Aviv University, Vice President of the Healthy Longevity Medicine Society.
“Our Vision of health outcomes is that vital intersection of science, cutting-edge technology, and preventive medicine.”
Fritz Schärer has led KEYONIQ as Group Managing Director since its founding in 2023. He brings over 30 years of international leadership experience across healthcare, security and manufacturing.
With a background in engineering, business and marketing administration, he combines strategic thinking, commercial focus and hands-on leadership to turn innovation into viable businesses.
At KEYONIQ, he and his team bring together science, technology and medical expertise to make preventive healthcare efficient, accessible and affordable, helping people live healthier, longer lives.
Meet the KEYONIQ Scientific and Medical Advisory Board.
Professor at Shanghai University of Medicine and Health Sciences and Tel Aviv University, Vice President of the Healthy Longevity Medicine Society.
Professor of Biochemistry and Physiology at the Yong Loo Lin School of Medicine, National University of Singapore.
Professor of Genomics, Physiology and Biophysics at Weill Cornell Medicine in New York, Director of WorldQuant Initiative for Quantitative Prediction Singapore.
Bioinformatician and ageing researcher at CECAD, University of Cologne. Project lead for central data integration in research unit FOR 5504 and lead author of SevenAge™.
Specialist in Orthopaedic Surgery and Traumatology of the Musculoskeletal System.
Specialist in Internal Medicine, Cardiology, Anti-Aging and Regenerative Medicine at Bumrungrad International Hospital and VitalLife Clinic.
Join a Swiss team with the backing of a leading hospital group. We are growing across clinical care, data science, regulatory affairs and commercial partnerships.